PLoS ONE (Feb 2011)

Labeling of multiple HIV-1 proteins with the biarsenical-tetracysteine system.

  • Cândida F Pereira,
  • Paula C Ellenberg,
  • Kate L Jones,
  • Tara L Fernandez,
  • Redmond P Smyth,
  • David J Hawkes,
  • Marcel Hijnen,
  • Valérie Vivet-Boudou,
  • Roland Marquet,
  • Iain Johnson,
  • Johnson Mak

DOI
https://doi.org/10.1371/journal.pone.0017016
Journal volume & issue
Vol. 6, no. 2
p. e17016

Abstract

Read online

Due to its small size and versatility, the biarsenical-tetracysteine system is an attractive way to label viral proteins for live cell imaging. This study describes the genetic labeling of the human immunodeficiency virus type 1 (HIV-1) structural proteins (matrix, capsid and nucleocapsid), enzymes (protease, reverse transcriptase, RNAse H and integrase) and envelope glycoprotein 120 with a tetracysteine tag in the context of a full-length virus. We measure the impact of these modifications on the natural virus infection and, most importantly, present the first infectious HIV-1 construct containing a fluorescently-labeled nucleocapsid protein. Furthermore, due to the high background levels normally associated with the labeling of tetracysteine-tagged proteins we have also optimized a metabolic labeling system that produces infectious virus containing the natural envelope glycoproteins and specifically labeled tetracysteine-tagged proteins that can easily be detected after virus infection of T-lymphocytes. This approach can be adapted to other viral systems for the visualization of the interplay between virus and host cell during infection.